✦ LIBER ✦

Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver

✍ Scribed by PE Ballmer; J Reichen; MA McNurlan; AB Sterchi; SE Anderson; PJ Garlick

Book ID: 118686371
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 239 KB
Volume: 24
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.1996.v24.pm0008707282

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Albumin but not fibrinogen synthesis cor

Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver

✍ P E Ballmer; J Reichen; M A McNurlan; A B Sterchi; S E Anderson; P J Garlick 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

tion impairment. Coagulation factors, in particular plasma Albumin and fibrinogen synthesis rates were meafibrinogen, can likewise reflect liver function. However, a sured in 15 subjects with different clinical stages of postsubstantial decrease in plasma fibrinogen concentration beviral cirrhosis a

Albumin but not fibrinogen synthesis is

Albumin but not fibrinogen synthesis is indicative of liver function as assessed by galactose elimination capacity in patients with postviral liver cirrhosis

✍ P.E. Ballmer; J. Reichen; M.A. McNurlan; S.E. Anderson; P.J. Garlick 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 142 KB

The Galactose Elimination Capacity in Co

The Galactose Elimination Capacity in Control Subjects and in Patients with Cirrhosis of the Liver

✍ TYGSTRUP, NIELS 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 541 KB

[233] GALACTOSE ELIMINATION CAPACITY IS

[233] GALACTOSE ELIMINATION CAPACITY IS A PREDICTOR OF SURVIVAL TIME IN PATIENTS WITH CIRRHOSIS OF THE LIVER

✍ P. Jepsen; H. Vilstrup; H.T. Sorensen; P. Ott; S. Keiding; P.K. Andersen; N. Tyg 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 274 KB

753 THE GALACTOSE ELIMINATION CAPACITY A

753 THE GALACTOSE ELIMINATION CAPACITY AND MORTALITY IN 781 DANISH PATIENTS WITH NEWLY- DIAGNOSED LIVER CIRRHOSIS: A COHORT STUDY

✍ P. Jepsen; H. Vilstrup; P. Ott; S. Keiding; P.K. Andersen; N. Tygstrup 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 93 KB

The course of galactose elimination capa

The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death

✍ C Merkel; G Marchesini; A Fabbri; S Bianco; G Bianchi; E Enzo; D Sacerdoti; M Zo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## ditions and in response to other treatments. (HEPATOL- There is increasing interest for the use of surrogate OGY 1996;24:820-823.) end points in the evaluation of treatments in patients with liver disease, but adequate validation is seldom Recent research in clinical epidemiology focused on th